Advances in ex vivo models and lab-on-a-chip devices for neural tissue engineering
-
Add time:08/12/2019 Source:sciencedirect.com
The technologies related to ex vivo models and lab-on-a-chip devices for studying the regeneration of brain, spinal cord, and peripheral nerve tissues are essential tools for neural tissue engineering and regenerative medicine research. The need for ex vivo systems, lab-on-a-chip technologies and disease models for neural tissue engineering applications are emerging to overcome the shortages and drawbacks of traditional in vitro systems and animal models. Ex vivo models have evolved from traditional 2D cell culture models to 3D tissue-engineered scaffold systems, bioreactors, and recently organoid test beds. In addition to ex vivo model systems, we discuss lab-on-a-chip devices and technologies specifically for neural tissue engineering applications. Finally, we review current commercial products that mimic diseased and normal neural tissues, and discuss the future directions in this field.
We also recommend Trading Suppliers and Manufacturers of Ex 169 (cas 132420-05-4). Pls Click Website Link as below: cas 132420-05-4 suppliers
Prev:The accuracy of benefit-cost analyses (BCAs) in transportation: An ex-post evaluation of road projects
Next:The puzzle of 16 days between the ex-dividend and payment dates) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Transient thermal analysis and structural assessment of an ex-vessel LOCA event on the EU DEMO HCPB breeding blanket and the attachment system08/18/2019
- Epigenetic and transcriptional signatures of ex situ conserved golden snub-nosed monkeys (Rhinopithecus roxellana)08/17/2019
- A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases08/16/2019
- Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation08/15/2019
- Immunoreactive properties of α-casein and κ-casein: Ex vivo and in vivo studies08/14/2019
- The puzzle of 16 days between the ex-dividend and payment dates08/13/2019
- The accuracy of benefit-cost analyses (BCAs) in transportation: An ex-post evaluation of road projects08/11/2019
- In vitro and ex vivo systems at the forefront of infection modeling and drug discovery08/10/2019
- Futures minimum variance hedge ratio determination: An ex-ante analysis08/09/2019


